Dossier
polyendocrine metabolic ovarian syndrome (PMOS)
Coverage of polyendocrine metabolic ovarian syndrome (PMOS) in the Nexus archive.
- Name of common medical condition could be misleading patients, experts warn
The name of Polycystic-ovarian syndrome (PCOS) has been changed to polyendocrine metabolic ovarian syndrome (PMOS) due to its inaccuracy in describing the condition. PMOS affects one in eight women and causes a variety of symptoms, including irregular periods and weight gain. The name change aims to reduce delayed diagnosis and stigma.
- ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women
Polycystic ovary syndrome (PCOS) has been renamed to polyendocrine metabolic ovarian syndrome (PMOS) after a decade-long global consultation. The condition affects one in eight women and an estimated 170 million women worldwide. The name change aims to reduce confusion and suffering for those affected.